Technical advances in surgery for pancreatic cancer

Published on Jul 23, 2021in British Journal of Surgery5.676
· DOI :10.1093/BJS/ZNAB133
Martin Schneider23
Estimated H-index: 23
(Heidelberg University),
T. Hackert17
Estimated H-index: 17
(Heidelberg University)
+ 1 AuthorsM.W. Büchler79
Estimated H-index: 79
(Heidelberg University)
BACKGROUND Multimodal treatment concepts enhance options for surgery in locally advanced pancreatic ductal adenocarcinoma (PDAC). This review provides an overview of technical advances to facilitate curative-intent resection in PDAC. METHODS A review of the literature addressing current technical advances in surgery for PDAC was performed, and current state-of-the-art surgical techniques summarized. RESULTS Artery-first and uncinate-first approaches, dissection of the anatomical triangle between the coeliac and superior mesenteric arteries and the portomesenteric vein, and radical antegrade modular pancreatosplenectomy were introduced to enhance the completeness of resection and reduce the risk of local recurrence. Elaborated techniques for resection and reconstruction of the mesenteric-portal vein axis and a venous bypass graft-first approach frequently allow resection of PDAC with venous involvement, even in patients with portal venous congestion and cavernous transformation. Arterial involvement does not preclude surgical resection per se, but may become surgically manageable with recent techniques of arterial divestment or arterial resection following neoadjuvant treatment. CONCLUSION Advanced techniques of surgical resection and vessel reconstruction provide a toolkit for curative-intent surgery in borderline resectable and locally advanced PDAC. Effects of these surgical approaches on overall survival remain to be proven with high-level clinical evidence.
📖 Papers frequently viewed together
22 Citations
1 Author (Mark J. Truty)
1 Citations
#1André L. Mihaljevic (Heidelberg University)H-Index: 20
#2Thilo Hackert (Heidelberg University)H-Index: 57
Last. Markus W. Büchler (Heidelberg University)H-Index: 173
view all 12 authors...
Abstract Background Pancreatoduodenectomy is the standard treatment for pathologies of the pancreatic head and is performed routinely worldwide. The aim of the study was to analyze this procedure in terms of extent of surgery, technical difficulty, and clinical outcomes and thereby provide a standardized surgical categorization of pancreatoduodenectomies for future reference. Methods For this cohort study, all patients who underwent pancreatoduodenectomy at a single center within an 18-year peri...
3 CitationsSource
#1Markus K. Diener (Heidelberg University)H-Index: 48
#2André L. Mihaljevic (Heidelberg University)H-Index: 20
Last. Markus W. Büchler (Heidelberg University)H-Index: 173
view all 14 authors...
Abstract Background Modern pancreatic cancer surgery changed with the introduction of effective neoadjuvant therapies. Complete tumor resection is the mainstay for long-term, disease-free, and overall survival and has been a prerequisite for decreasing local recurrence. The medial resection margin in the area of the superior mesenteric vessels limits the radicalness of the resection, especially in borderline and locally advanced cases. Therefore, the periarterial soft tissue around the peripancr...
15 CitationsSource
#1Baobao Cai (Nanjing Medical University)H-Index: 9
#2Zipeng Lu (Nanjing Medical University)H-Index: 18
Last. Yi Miao (Nanjing Medical University)H-Index: 33
view all 18 authors...
PURPOSE To introduce sub-adventitial divestment technique (SDT), a procedure to remove the tumor while preserving the artery during curative pancreatectomy. Peri-operative safety profile was also evaluated. METHODS In a single center consecutive series of pancreatectomy for pancreatic cancer, the outcome of patients who had pancreatectomy with SDT was compared to standard pancreatic surgery. RESULTS From June 2014 to June 2016, 72 patients had pancreatectomy with SDT and 235 had standard surgery...
4 CitationsSource
#1Thomas Schmidt (Heidelberg University)H-Index: 31
#2Oliver Strobel (Heidelberg University)H-Index: 50
Last. Markus W. Büchler (Heidelberg University)H-Index: 173
view all 10 authors...
Background In recent years, several techniques have been introduced to allow safe oncologic resections of cancers of the pancreatic head. While resections of the mesenterico-portal axis became now a part of the routine treatment, patients with a cavernous transformation of the portal vein still pose a surgical challenge and are regularly deemed unresectable. Objective Here, we describe a technique of initial venous bypass graft placement between the superior mesenteric vein or its tributaries an...
4 CitationsSource
#1Artur Rebelo (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 3
#2Ibrahim Büdeyri (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 1
Last. Jörg Kleeff (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 94
view all 8 authors...
OBJECTIVE Advances in multimodality treatment paralleled increasing numbers of complex pancreatic procedures with major vascular resections. The aim of this meta-analysis was to evaluate the current outcomes of arterial resection (AR) in pancreatic surgery. METHODS A systematic literature search was carried out from January 2011 until January 2020. MOOSE guidelines were followed. Predefined outcomes were morbidity, pancreatic fistula, postoperative bleeding and delayed gastric emptying, reoperat...
7 CitationsSource
#1Oliver Strobel (University Hospital Heidelberg)H-Index: 50
#2Philipp Lorenz (University Hospital Heidelberg)H-Index: 1
Last. Markus W. Büchler (University Hospital Heidelberg)H-Index: 173
view all 19 authors...
OBJECTIVE To determine actual five-year survival (5YS) rates associated with a strategy of upfront surgery and adjuvant therapy in pancreatic ductal adenocarcinoma (PDAC). BACKGROUND The rate of actual 5YS in PDAC remains controversial. Available data is restricted to cohorts acquired over several decades and series of resection after patient selection by neoadjuvant therapy. METHODS All patients undergoing upfront resection for resectable and borderline-resectable PDAC from 10/2001 to 12/2011 w...
16 CitationsSource
#1Thomas Hank (Harvard University)H-Index: 11
#2Marta Sandini (Harvard University)H-Index: 15
Last. Carlos Fernandez-del Castillo (Harvard University)H-Index: 101
view all 21 authors...
OBJECTIVE To build a prognostic score for patients with primary chemotherapy undergoing surgery for pancreatic cancer based on pathological parameters and preoperative Carbohydrate antigen 19-9 (CA19-9) levels. BACKGROUND Prognostic stratification after primary chemotherapy for pancreatic cancer is challenging and prediction models, such as the AJCC staging system, lack validation in the setting of preoperative chemotherapy. METHODS Patients with primary chemotherapy resected at the Massachusett...
2 CitationsSource
#1Martin Loos (University Hospital Heidelberg)H-Index: 2
#2Tobias KesterH-Index: 1
Last. Markus W. BüchlerH-Index: 173
view all 14 authors...
OBJECTIVE To investigate the perioperative and oncologic long-term outcomes of patients with LAPC after surgical resection at a high-volume center for pancreatic surgery. BACKGROUND The role of surgery in LAPC with arterial involvement is controversial. METHODS We analyzed 385 consecutive patients undergoing PAR (n = 195) or PAD (n = 190) of the encased artery for LAPC between January 1, 2003 and April 30, 2019. RESULTS There were 183 total pancreatectomies, 113 partial pancreatoduodenectomies, ...
16 CitationsSource
#1Philippe Bachellier (UDS: University of Strasbourg)H-Index: 59
#2Pietro Addeo (UDS: University of Strasbourg)H-Index: 27
Last. Patrick Dufour (UDS: University of Strasbourg)H-Index: 26
view all 5 authors...
Objective:This study assesses the safety and outcomes of the largest cohort of pancreatectomy with arterial resection (P-AR).Background:A high postoperative mortality rate and uncertain oncologic benefits have limited the use of P-AR for locally advanced pancreatic adenocarcinoma.Methods:We retrospe
54 CitationsSource
#1Martin Schneider (Heidelberg University)H-Index: 23
#2Oliver Strobel (Heidelberg University)H-Index: 50
Last. Markus W. Büchler (Heidelberg University)H-Index: 173
view all 4 authors...
Background Pancreatic cancer is associated with high recurrence rates, and any surgery should aim to prevent local recurrence. However, systematic resection of putatively tumor-infiltrated soft tissue adjacent to the celiac branches and superior mesenteric artery has not regularly been applied in pancreatic head resection.
22 CitationsSource
Cited By5
#1Mohammed Al-Saeedi (University Hospital Heidelberg)H-Index: 8
#2Leonie Frank-Moldzio (University Hospital Heidelberg)
Last. Arianeb Mehrabi (University Hospital Heidelberg)H-Index: 33
view all 13 authors...
Resection of the portal venous confluence is frequently necessary for radical resection during pancreatoduodenectomy for cancer. However, ligation of the splenic vein can cause serious postoperative complications such as gastric/splenic venous congestion and left-sided portal hypertension. A splenorenal shunt (SRS) can maintain gastric and splenic venous drainage and mitigate these complications. This study describes the surgical technique, postoperative course, and surgical outcomes of SRS afte...
#1Susanne Roth (University Hospital Heidelberg)H-Index: 11
#2Thilo Hackert (University Hospital Heidelberg)H-Index: 57
Das Pankreaskarzinom ist eine sehr aggressive Krebserkrankung mit einer auserst schlechten Prognose. Das Uberleben der Patienten in samtlichen Tumorstadien ist jedoch sehr unterschiedlich. Standardtherapien, die sich uberwiegend an TNM-Klassifikation, Allgemeinzustand und Komorbiditat orientieren, sind in ihrer Effektivitat sehr variabel. Neue Technologien mit Multi-omics-Tumorcharakterisierungen haben in den letzten Jahren die molekulare Heterogenitat des Pankreaskarzinoms aufgezeigt. In der kl...
Periampullare Neoplasien sind eine heterogene Gruppe verschiedener Tumorentitaten der periampullaren Region, von denen das Pankreasadenokarzinom mit 60–70 % am haufigsten ist. Wie typisch fur Pankreaskarzinome zeichnen sich periampullare Pankreaskarzinome durch ein aggressives Wachstum und eine fruhe systemische Progression aus. Aufgrund ihrer besonderen Lage in unmittelbarer Nahe zur Papilla Vateri treten Symptome in eher fruherem Tumorstadium auf, sodass die Therapiemoglichkeiten und Prognose ...
#1Martin Schneider (University Hospital Heidelberg)H-Index: 23
#2Markus W. Büchler (University Hospital Heidelberg)H-Index: 173
Die chirurgische Therapie endoskopisch nicht sanierbarer Adenome und von Karzinomen der Papilla duodeni major (Vateri) und Ampulla hepatopancreatica erfordert eine differenzierte Indikationsstellung sowie eine an das Infiltrationsverhalten dieser Tumoren angepasste Operationstechnik. Basierend auf aktuellen wissenschaftlichen Daten und Entwicklungen sollen die Indikationen zur chirurgischen Resektion, chirurgische Strategien und Dissektionstechniken bei Papillentumoren dargestellt werden. Die ak...
#1Benedict Kinny-Köster (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 3
#2Joseph R. Habib (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 6
Last. Jin He (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 40
view all 10 authors...
Purpose null The resection of retropancreatic nerve plexuses for pancreatic head cancer became standard of care during open pancreatoduodenectomy to minimize local recurrences. Since more surgical centers are progressing on the learning curve, robotically-assisted pancreatoduodenectomy is now increasingly performed with decreasing anatomic exclusion criteria. To achieve comparable and favorable oncologic outcomes, advanced surgical techniques should be transferred and implemented when performing...